Some variants in SLC22A5 cause primary systemic carnitine deficiency, skeletal myopathy, or cardiomyopathy (O’Leary et al. 2016), due to a defect in the carnitine transporter. This evidence concerns the gene SLC22A5 and cardiomyopathy.